Purchase Order W81K0223P0110
Award Date 8/29/23
Potential Completion Date 9/30/23
Potential Value $58K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and bioinformatics solutions. The contract has a ceiling value of $4,909.67 and a period of performance through April 11, 2025. The contract covers the "EXERCISE FULL AGREEMENT FOR EZ1 ADVANCED" requirement, which likely involves the provision of Qiagen's EZ1 DNA/RNA extraction equipment and...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC for the delivery of EZ1 DNA BLOOD 350 UL KITS (48). The contract has a ceiling value of $20,961.12 and a completion date of September 29, 2019. Qiagen, LLC is a division of the international provider of sample and assay technologies, Qiagen N.V. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
- This federal contract award, valued at $77,258.10, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense to Qiagen, LLC for the provision of the EZ1 Advanced XL Platform. Qiagen, LLC is a subsidiary of the Qiagen N.V. multinational biotechnology company. The contract is a firm fixed-price purchase order without a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and life sciences research. Under this...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer, for $10,026.00 to provide preventative maintenance services for two EZ1 Advanced XL laboratory instruments located at the Naval Medical Research Command's Infectious Diseases Diagnostic Laboratory. The contract has a 12-month period of performance from April 12, 2025 to April 11, 2026 and was awarded without any set-aside designation....
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Criminal Investigation Command to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $147,918.74, is for the provision of EZ1 equipment and associated services under the base year of a full agreement. The contract does not utilize any set-aside designations. Qiagen, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and...
- This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $10,546.00 contract is for QIAXTRACTOR/QIACUBE HT SERVICE, which are likely equipment maintenance and service support for Qiagen's sample processing and diagnostic systems used in federal biomedical research, public health, and healthcare programs. Qiagen has a history of providing a range of products and services to...
- This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....